1. Home
  2. DPRO vs ACHV Comparison

DPRO vs ACHV Comparison

Compare DPRO & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DPRO
  • ACHV
  • Stock Information
  • Founded
  • DPRO 1998
  • ACHV N/A
  • Country
  • DPRO Canada
  • ACHV United States
  • Employees
  • DPRO N/A
  • ACHV 25
  • Industry
  • DPRO Aerospace
  • ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • DPRO Industrials
  • ACHV Health Care
  • Exchange
  • DPRO Nasdaq
  • ACHV Nasdaq
  • Market Cap
  • DPRO 175.1M
  • ACHV 167.6M
  • IPO Year
  • DPRO N/A
  • ACHV N/A
  • Fundamental
  • Price
  • DPRO $12.80
  • ACHV $3.16
  • Analyst Decision
  • DPRO Strong Buy
  • ACHV Strong Buy
  • Analyst Count
  • DPRO 1
  • ACHV 1
  • Target Price
  • DPRO $14.00
  • ACHV $12.00
  • AVG Volume (30 Days)
  • DPRO 8.6M
  • ACHV 729.3K
  • Earning Date
  • DPRO 11-13-2025
  • ACHV 11-06-2025
  • Dividend Yield
  • DPRO N/A
  • ACHV N/A
  • EPS Growth
  • DPRO N/A
  • ACHV N/A
  • EPS
  • DPRO N/A
  • ACHV N/A
  • Revenue
  • DPRO $5,250,872.00
  • ACHV N/A
  • Revenue This Year
  • DPRO $41.59
  • ACHV N/A
  • Revenue Next Year
  • DPRO $137.37
  • ACHV N/A
  • P/E Ratio
  • DPRO N/A
  • ACHV N/A
  • Revenue Growth
  • DPRO 17.08
  • ACHV N/A
  • 52 Week Low
  • DPRO $1.63
  • ACHV $1.84
  • 52 Week High
  • DPRO $13.54
  • ACHV $5.31
  • Technical
  • Relative Strength Index (RSI)
  • DPRO 81.16
  • ACHV 52.94
  • Support Level
  • DPRO $9.30
  • ACHV $3.07
  • Resistance Level
  • DPRO $12.12
  • ACHV $3.48
  • Average True Range (ATR)
  • DPRO 1.39
  • ACHV 0.15
  • MACD
  • DPRO 0.53
  • ACHV 0.01
  • Stochastic Oscillator
  • DPRO 81.47
  • ACHV 39.45

About DPRO Draganfly Inc.

Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Share on Social Networks: